Mar 31, 2025 / 08:30PM GMT
Operator
Welcome to the conference call hosted by Dare Bioscience to review the company's 2024 financial results and to provide a business update. This call is being recorded. My name is Jericho, and I'll be your operator today. With us today from Dare are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer.
Ms. Haring-Layton, please proceed.
MarDee Haring-Layton - Dare Bioscience Inc - Chief Accounting Officer
Good afternoon, and welcome to the Dare Bioscience financial results and business update call for the year ended December 31, 2024. Today, we will review our results, discuss developments and expectations for our pipeline and portfolio, and discuss our expanded business strategy to include 503B compounding as a dual path approach to bring some of our proprietary formulations to market as soon as practical.
I would like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant
Q4 2024 Dare Bioscience Inc Earnings Call Transcript
Apr 01, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers